Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15264729rdf:typepubmed:Citationlld:pubmed
pubmed-article:15264729lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:15264729lifeskim:mentionsumls-concept:C2752561lld:lifeskim
pubmed-article:15264729lifeskim:mentionsumls-concept:C0473296lld:lifeskim
pubmed-article:15264729lifeskim:mentionsumls-concept:C0002928lld:lifeskim
pubmed-article:15264729lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:15264729lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:15264729pubmed:issue3lld:pubmed
pubmed-article:15264729pubmed:dateCreated2004-7-21lld:pubmed
pubmed-article:15264729pubmed:abstractTextCurrent methods of crystalloid preload administration prior to spinal anaesthesia for elective caesarean section are relatively ineffective in preventing hypotension. This study examined the relevance of the timing of the fluid administered. Fifty women were randomly allocated to receive either 20 ml x kg(-1) of crystalloid solution during 20 minutes prior to induction of spinal anaesthesia (preload), or an equivalent volume by rapid infusion immediately after induction (coload). Significantly more patients in the coload group did not require vasopressor therapy pre-delivery (P=0.047). The coload group required a lower median dose (P=0.03) and a lower median number (P=0.04) of ephedrine doses for the treatment of maternal hypotension pre-delivery. There was no between-group difference in either the total cumulative dose, or in the total number of doses of ephedrine. Neonatal outcomes among the two groups were similar. Rapid crystalloid administration after, rather than over 20 minutes before the induction of spinal anaesthesia for elective caesarean section, may be advantageous in terms of managing maternal blood pressure prior to delivery.lld:pubmed
pubmed-article:15264729pubmed:languageenglld:pubmed
pubmed-article:15264729pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:citationSubsetIMlld:pubmed
pubmed-article:15264729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15264729pubmed:statusMEDLINElld:pubmed
pubmed-article:15264729pubmed:monthJunlld:pubmed
pubmed-article:15264729pubmed:issn0310-057Xlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:MeyerMMlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:FariniRRlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:Du ToitPPlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:WellsKKlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:DyerR ARAlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:TortAAlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:JamesM F MMFlld:pubmed
pubmed-article:15264729pubmed:authorpubmed-author:JoubertI AIAlld:pubmed
pubmed-article:15264729pubmed:issnTypePrintlld:pubmed
pubmed-article:15264729pubmed:volume32lld:pubmed
pubmed-article:15264729pubmed:ownerNLMlld:pubmed
pubmed-article:15264729pubmed:authorsCompleteYlld:pubmed
pubmed-article:15264729pubmed:pagination351-7lld:pubmed
pubmed-article:15264729pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:meshHeadingpubmed-meshheading:15264729...lld:pubmed
pubmed-article:15264729pubmed:year2004lld:pubmed
pubmed-article:15264729pubmed:articleTitleCrystalloid preload versus rapid crystalloid administration after induction of spinal anaesthesia (coload) for elective caesarean section.lld:pubmed
pubmed-article:15264729pubmed:affiliationDepartment of Anaesthesia, University of Cape Town, Cape Town, South Africa.lld:pubmed
pubmed-article:15264729pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15264729pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15264729pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15264729pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15264729pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15264729lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15264729lld:pubmed